Use of pharmacotherapies for treatment resistant depression in finland: A nationwide cohort study by H. Taipale, M. Lähteenvuo, A. Tanskanen, S. Rannanpää, J. Tiihonen

Get full text

Healthcare costs and productivity losses in treatment-resistant depression in Finland by S. Rannanpää, H. Taipale, A. Tanskanen, M. Lähteenvuo, S. Huoponen, J. Tiihonen

Get full text

Psychotic depression and the risk of death due to suicide by T. Paljarvi, J. Tiihonen, M. Lähteenvuo, A. Tanskanen, S. Fazel, H. Taipale

Get full text

Antidepressant use and psychosis hospitalization in persons with schizophrenia by A. Puranen, M. Koponen, M. Lähteenvuo, A. Tanskanen, J. Tiihonen, H. Taipale

Get full text

Morbidity and mortality in schizophrenia with comorbid substance use disorders in Finland and Sweden by M. Lähteenvuo, A. Batalla, J. Luykx, E. Mittendorfer-Rutz, A. Tanskanen, J. Tiihonen, H. Taipale

Get full text

Effectiveness of antipsychotics in schizophrenia with comorbid substance use disorder by M. Lähteenvuo, J. Luykx, H. Taipale, E. Mittendorfer-Rutz, A. Tanskanen, A. Batalla, J. Tiihonen

Get full text

Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders by C. Okhuijsen-Pfeifer, M. Z. van der Horst, C. A. Bousman, B. Lin, K. R. van Eijk, S. Ripke, Y. Ayhan, M. O. Babaoglu, M. Bak, W. Alink, H. van Beek, E. Beld, A. Bouhuis, M. Edlinger, I. M. Erdogan, A. Ertuğrul, G. Yoca, I. P. Everall, T. Görlitz, GROUP (Genetic Risk and Outcome of Psychosis) investigators, K. P. Grootens, S. Gutwinski, T. Hallikainen, E. Jeger-Land, M. de Koning, M. Lähteenvuo, S. E. Legge, S. Leucht, C. Morgenroth, A. Müderrisoğlu, A. Narang, C. Pantelis, A. F. Pardiñas, T. Oviedo-Salcedo, J. Schneider-Thoma, S. Schreiter, E. Repo-Tiihonen, H. Tuppurainen, M. Veereschild, S. Veerman, M. de Vos, E. Wagner, D. Cohen, J. P. A. M. Bogers, J. T. R. Walters, A. E. Anil Yağcıoğlu, J. Tiihonen, A. Hasan, J. J. Luykx

Get full text